Deaths from septic shock in U.S. hospitals increased during a 2011 shortage of norepinephrine, the front-line vasopressor drug used to treat the condition, researchers report.
Septic shock deaths during that norepinephrine shortage period increased from 35.9% to 39.6% in a retrospective analysis of a nationally representative sample of hospitals.
No comments:
Post a Comment